An observational study in Development; Unilateral, sponsored by Laurent Chapelle. Status unknown at 1 site in Belgium. Open to participants aged 8 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-25.
Sponsored by Laurent Chapelle · Observational
Humans generally develop a preferred upper and lower extremity. Due to repetitive uneven loading, this gradually results in structural (e.g. increased bone and muscle mass) and functional (e.g. increased strength) adaptations to the dominant side of the body. The corresponding structural and functional asymmetry can be further accentuated by (intensively) practicing a unilateral sport such as tennis, which is very popular. Yet, research on this particular topic is scarce, especially in (pre)adolescent players. Existing studies, which often face methodological shortcomings (e.g. crosssectional designs, small sample sizes, no link to field methods), mainly focus on adults and structural asymmetry of the upper extremity itself, with very little or no attention to whole body structural as well as functional asymmetry. Moreover, the link of both forms of asymmetry with growth and maturation, everyday locomotion, technical skill performance and whole body injury is currently not (fully) understood. Therefore, the main purpose of this research project is to gain comprehensive knowledge on the degree, development and implications of both structural and functional asymmetry during a critical period in life using a longitudinal approach. As such, this project among youth elite tennis players will provide insights on the extent to which structural and/or functional asymmetry is acceptable for being most successful but remaining injury free.
This is the only study on the registry with Laurent Chapelle as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Young elite tennis players enrolled in Belgian high-performance tennis academies as well as age- and gender-matched (within two months) controls.
Exclusion Criteria:
Anthropometry
Stature (cm) Sitting height (cm) Upper- and lower extremity length (cm) body weight (kg) Body Mass Index (kg/m²) Age at Peak height Velocity (years) Skeletal muscle mass (kg) These values will be determined every two months during a maximum period of three years, expressed as mean and standard deviation and will be used to develop growth charts and velocity curves.
Time frame: September 2017 - December 2020
Body composition
Dual X-Ray Absorptiometry * lean mass (g) * fat mass (g) * bone mass (g) * total bone area (cm²) * Bone Mineral Content (g) * Bone Mineral Density (g/cm²) Circumferences - upper and lower arm, thigh and calf (in cm) Ultrasound - Muscle thickness ((in mm) of M. Biceps, M. Triceps, M. Rectus Abdominis, Quadriceps and Hamstrings) Bioelectric impedance * fat (g) * fat free mass (g) These outcome measures will be determined on both the dominant and the non-dominant extremity/side every six months during a maximum period of three years. The side-to-side difference will be calculated using the symmetry index (see outcome measure 4). Every outcome measure described above will be expressed as mean and standard deviation for both the dominant and non-dominant extremity/side
Time frame: September 2017 - December 2020
Functional test battery
Strength and Power: * Seated shot put functional test (distance in cm) * Grip Strength (kg) * Unilateral countermovement jump (distance in cm) * Single hop test (distance in cm) * Medicine Ball throws (distance in cm) Speed and Agility: * Plate tapping (time s) * Single leg 6-m hop test (time in s) Balance and Flexibility: * Upper- and Lower extremity Y-balance test (distance in cm) * Standing On One Leg with Eyes Closed (time in s) Motor control and Coordination: * Unilateral hand wall toss test (score in points) * 270 degrees tap test (time in s) Locomotion pattern: - Ground Reaction Forces (force in N) Every test will be performed unilaterally for both the dominant and non-dominant extremity/side every six months during a maximum period of three years. The side-to-side difference will be calculated using the symmetry index (see outcome measure 4). The mean (plus standard deviation) of every test (dominant and non-dominant test score) will be reported
Time frame: September 2017 - December 2020
Structural and functional asymmetry index
Side-to-side difference (i.e. dominant vs non-dominant extremity/side) will be calculated and expressed as a percentage (extremity symmetry index (%)) for the outcome measures described above (anthropometry, body composition and functional test battery) using following formula: ((measure dominant extremity/measure non-dominant extremity)-1) x 100
Time frame: September 2017 - December 2020
Injury incidence
Injury incidence in young elite tennis players (patterns and occurence) will be recorded and reported continuously for a maximum period of three years.
Time frame: September 2017 - December 2020
Technical tennis skills performance
technical skill of young elite tennis players. - Technical skill performance will be examined by means of video analysis once a year and scored by an independent expert panel. Mean technical ability will be reported. Tennis specific performance: - Tennis players will perform the Dutch Technical-Tactical Tennis Test (D4T) once a year. The mean test score will be reported.
Time frame: September 2017 - December 2020
Plan to share: No — Individual Participant Data (IPD) will not be shared or will not be available to other researchers
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.